Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center

被引：1
|
作者：
Bobby, Lauren [1 ]
Westlake, Evan [1 ]
Esplin, Nathan [2 ]
Young, Sarah [1 ]
机构：
[1] Allegheny Gen Hosp, Dept Pharm, 320 North Ave, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Dept Neurosurg, 320 North Ave, Pittsburgh, PA 15212 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 206卷
关键词：
Apixaban; Rivaroxaban; Reversal; Activated prothrombin complex concentrate (aPCC); Intracranial hemorrhage (ICH); Andexanet alfa; ANTICOAGULANTS; MANAGEMENT; OUTCOMES; FEIBA;
D O I：
10.1016/j.thromres.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 35
页数：3
相关论文
共 50 条
  • [11] How should we measure the reversal of direct factor XA or thrombin inhibitors by prothrombin complex concentrate?
    Brinkman, H. J. M.
    Dinkelaar, J.
    Patiwael, S.
    Harenberg, J.
    Leyte, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 16 - 16
  • [12] Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors
    Hormese, Mary
    Littler, Alex
    Doane, Brian
    Glowacki, Nicole
    Khimani, Ann
    Vivacqua, Nicole
    Rudenberg, Karina
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 828 - 835
  • [13] Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors
    Mary Hormese
    Alex Littler
    Brian Doane
    Nicole Glowacki
    Ann Khimani
    Nicole Vivacqua
    Karina Rudenberg
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 828 - 835
  • [14] Use of prothrombin complex concentrate and activated prothrombin complex concentrate for reversal of direct oral anticoagulant associated bleeding
    Castellucci, L. A.
    Shaw, J.
    Le Gal, G.
    Tokessy, M.
    Cober, N.
    Saidenberg, E.
    Carrier, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 623 - 624
  • [15] Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors
    Gundabolu, Krishna
    Trevarrow, Brian
    Koepsell, Scott A.
    BLOOD, 2015, 126 (23)
  • [16] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Abdalla A. Ammar
    Mahmoud A. Ammar
    Kent A. Owusu
    Stacy C. Brown
    Firas Kaddouh
    Aladine A. Elsamadicy
    Julián N. Acosta
    Guido J. Falcone
    Neurocritical Care, 2021, 35 : 255 - 261
  • [17] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Ammar, Abdalla A.
    Ammar, Mahmoud A.
    Owusu, Kent A.
    Brown, Stacy C.
    Kaddouh, Firas
    Elsamadicy, Aladine A.
    Acosta, Julian N.
    Falcone, Guido J.
    NEUROCRITICAL CARE, 2021, 35 (01) : 255 - 261
  • [18] Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors
    Schulman, Sam
    Bhagirath, Vinai
    Chan, Noel
    Germini, Federico
    Ikesaka, Rick
    Iorio, Alfonso
    Mithoowani, Siraj
    Weitz, Jeff I.
    Gross, Peter L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (10) : 2761 - 2766
  • [19] The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
    Nina Haagenrud Schultz
    Hoa Thi Tuyet Tran
    Stine Bjørnsen
    Carola Elisabeth Henriksson
    Per Morten Sandset
    Pål Andre Holme
    Thrombosis Journal, 15
  • [20] The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
    Schultz, Nina Haagenrud
    Hoa Thi Tuyet Tran
    Bjornsen, Stine
    Henriksson, Carola Elisabeth
    Sandset, Per Morten
    Holme, Pal Andre
    THROMBOSIS JOURNAL, 2017, 15
12345